Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 1

End of life care in chronic obstructive pulmonary disease: in search of a good death

Authors Anna Spathis, Sara Booth

Published Date March 2008 Volume 2008:3(1) Pages 11—29

DOI http://dx.doi.org/10.2147/COPD.S698

Published 18 March 2008

Anna Spathis, Sara Booth

Palliative Care Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, England, UK

Abstract: Chronic obstructive pulmonary disease (COPD) is an incurable, progressive illness that is the fourth commonest cause of death worldwide. Death tends to occur after a prolonged functional decline associated with uncontrolled symptoms, emotional distress and social isolation. There is increasing evidence that the end of life needs of those with advanced COPD are not being met by existing services. Many barriers hinder the provision of good end of life care in COPD, including the inherent difficulties in determining prognosis. This review provides an evidence-based approach to overcoming these barriers, summarising current evidence and highlighting areas for future research. Topics include end of life needs, symptom control, advance care planning, and service development to improve the quality of end of life care.

Keywords: chronic obstructive pulmonary disease (MeSH), palliative care (MeSH), dyspnoea (MeSH), advance care planning (MeSH)

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Pyrrolyl thiadiazoles as Mycobacterium tuberculosis inhibitors and their in silico analyses

Joshi SD, More UA, Sorathiya S, Koli D, Aminabhavi TM

Research and Reports in Medicinal Chemistry 2015, 5:1-20

Published Date: 28 April 2015

Helicobacter pylori infection in Chinese patients with atrial fibrillation

Wang DZ, Chen W, Yang S, Wang J, Li Q, Fu Q, Li SJ, Chen BX

Clinical Interventions in Aging 2015, 10:813-819

Published Date: 28 April 2015

Distinguishing adult-onset asthma from COPD: a review and a new approach

Abramson MJ, Perret JL, Dharmage SC, McDonald VM, McDonald CF

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:945-962

Published Date: 9 September 2014

Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silica [Erratum]

Wang Z, Chen B, Quan G, Li F, Wu Q, Dian L, Dong Y, Li G, Wu C

International Journal of Nanomedicine 2013, 8:627-628

Published Date: 7 February 2013

Blood–brain barrier: a real obstacle for therapeutics

Shiekh FA

International Journal of Nanomedicine 2012, 7:4065-4067

Published Date: 27 July 2012

Medicine at nanoscale: a new horizon

Khan AU

International Journal of Nanomedicine 2012, 7:2997-2998

Published Date: 18 June 2012

Corrigendum

Schneider EW, Johnson MW

Clinical Ophthalmology 2011, 5:1315-1316

Published Date: 16 September 2011

Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision

Espandar L, Sikder S, Moshirfar M

Clinical Ophthalmology 2011, 5:159-160

Published Date: 6 February 2011